Meters & Monitors

Blood Glucose Meters Current Continuous Monitors Comparison of Available Monitors
Various Future Monitors Improving Today's Meters Other Monitors Older Monitors

Future Monitoring

AiMedics A.Menarini Diagnostics Cybiocare OHD InLight Solutions Kumetrix LighTouch Medical NAS - iSense NIR Diagnostics Optiscan Orsense Pindi Products Sensors For Medicine and Science Sensys Medical Sentek Solianis Sontra SpectRx Synthetic Blood International Therasense Visual Pathways

Sentek

Sentek Group, Inc. is developing a non-invasive diagnostic tool targeting diabetes patients that uses a patented Crystalline Colloidal Array (CCA) technology exclusively licensed from the University of Pittsburgh. While Sentek plans to exploit several applications of the technology, the company’s first commercial efforts are for the Glucoview ocular insert that will enable diabetics to continuously monitor their blood glucose levels, and unlike most competing technologies, it will not require finger stabs.

Sentek believes that their Glucoview ocular insert distinguishes itself from all current and proposed technologies in four key ways:

• It is non-invasive (doesn’t require finger stabs)
• It requires no instrumentation (either to collect fluids or analyze results)
• It provides easily measurable, quantitative results
• It is a low-cost, continuous monitoring solution

For questions, contact:

Philipe Sommer, CEO
(212) 996-3628
alsasom@aol.com

Click Here to browse our secure, on-line store for a complete selection of diabetes books at 22%-50% off their cover price. You can also download our Diabetes Mall 2008 Catalog, email our Order Form, or call us at (800) 988-4772.

Back to Top